A multicenter study published in Frontiers in Neurology confirms the clinical effectiveness of TRACE4AD™, an Artificial Intelligence system developed by DeepTrace Technologies, a spinoff of the IUSS School for Advanced Studies Pavia. The tool supports clinicians in staging, defining the causal hypothesis of neurocognitive disorders, and predicting the progression to Alzheimer’s dementia within 24 months. TRACE4AD™ automatically analyzes brain MRI scans and cognitive tests, assisting medical decisions with 89% sensitivity.

Read the full article